Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 8/20 | 0.57 |
| ▸ | GART | P22102 | 5/20 | 0.57 |
| ▸ | TYMS | P04818 | 4/20 | 0.57 |
| ▸ | ATIC | P31939 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | TLR4 | O00206 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16583122 | 0.92 | DHFR (0.57) | DHFRGARTTYMSATICKDM4E | |
| SCHEMBL20486467 | 0.92 | DHFR (0.57) | DHFRGARTTYMSATICKDM4E | |
| SCHEMBL28344641 | 0.92 | DHFR (0.57) | DHFRGARTTYMSATICKDM4E | |
| SCHEMBL28135233 | 0.92 | DHFR (0.57) | DHFRGARTTYMSATICKDM4E | |
| SCHEMBL869876 | 0.92 | DHFR (0.57) | DHFRGARTTYMSATICKDM4E | |
| SCHEMBL25167471 | 0.92 | DHFR (0.57) | DHFRGARTTYMSATICKDM4E | |
| SCHEMBL3771709 | 0.91 | DHFR (0.56) | DHFRGARTTYMSATICKDM4E | |
| SCHEMBL28885296 | 0.91 | DHFR (0.56) | DHFRGARTTYMSATICKDM4E | |
| SCHEMBL15530423 | 0.91 | DHFR (0.56) | DHFRGARTTYMSATICKDM4E | |
| SCHEMBL29133794 | 0.91 | DHFR (0.56) | DHFRGARTTYMSATICKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109601757-A | A kind of feed addictive and complete feed quickly to become mildewed for guinea fowl | 河南牧业经济学院 | 2019-04-12 | — | — | CN | claimed |
| US-20110217263-A1 | EXPANSION OF HAEMOPOIETIC PRECURSORS | MESOBLAST LIMITED (AU) | 2011-09-08 | — | — | US | claimed |
| EP-2324109-A1 | EXPANSION OF HAEMOPOIETIC PRECURSORS | Angioblast Systems, Inc. (US) | 2011-05-25 | — | — | EP | claimed |
| EP-2077844-A2 | METHOD OF TREQATMENT AND COMPOSITIONS OF D-CHRIRO INOSITOL AND PHOSPHATES THEREOF | Jennings-Spring, Barbara L. (US) | 2009-07-15 | — | — | EP | claimed |
| WO-2008066634-A2 | METHOD OF TREQATMENT AND COMPOSITIONS OF D-CHRIRO INOSITOL AND PHOSPHATES THEREOF | JENNINGS-SPRING BARBARA L (US) | 2008-06-05 | — | — | WO | claimed |
| WO-2024137455-A1 | NANOPARTICULATE FORMULATION | NEWIMMUNE II, LLC (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2023010088-A1 | NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-COV-2 SPIKE PROTEINS, AND MRNA VACCINE SPIKE PROTEINS | PONO LIFESTYLE COLORADO, LLC (US) | 2023-02-02 | — | — | WO | disclosed |
| CN-112552300-B | Preparation method of 5-methyltetrahydrofolate hapten, antigen and monoclonal antibody | 深圳泰乐德医疗有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-20210392897-A1 | Topical Serum for Treating Damaged Plants | COHN KALENE MARIE (US) | 2021-12-23 | — | — | US | disclosed |
| US-11155816-B2 | Oligonucleotide conjugates | ROCHE INNOVATION CENTER COPENHAGEN A/S (CH) | 2021-10-26 | — | — | US | disclosed |
| US-20210238601-A1 | Oligonucleotide Conjugates | ROCHE INNOVATION CENTER COPENHAGEN A/S (CH) | 2021-08-05 | — | — | US | disclosed |
| CN-112961878-A | Application of gene of lactobacillus plantarum in folic acid biological generation | 昆明理工大学 | 2021-06-15 | — | — | CN | disclosed |
| WO-2008002470-A2 | SIRNA SEQUENCES AGAINST BRF1 | CALANDO PHARMACEUTICALS, INC. (US) | 2008-01-03 | — | — | WO | disclosed |
| EP-1765089-A2 | COMPOSITIONS COMPRISING EDIBLE OILS AND VITAMINS AND/OR MINERALS AND METHODS FOR MAKING THE COMPOSITIONS | PBM Pharmaceuticals, Inc. (US) | 2007-03-28 | — | — | EP | disclosed |
| US-20060188607-A1 | Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions | PBM PHARMACEUTICALS, INC. | 2006-08-24 | — | — | US | disclosed |
| WO-2005112654-A2 | COMPOSITIONS COMPRISING EDIBLE OILS AND VITAMINS AND/OR MINERALS AND METHODS FOR MAKING THE COMPOSITIONS | PBM PHARMACEUTICALS, INC. (US) | 2005-12-01 | — | — | WO | disclosed |
| WO-2005094265-A2 | SELF ASSEMBLING ACTIVATION AGENTS TARGETED USING ACTIVE DRUG RELEASE | HEMOLYTICS, INC. (US) | 2005-10-13 | — | — | WO | disclosed |
| EP-0951293-A4 | METHOD FOR TREATING ALZHEIMER'S DISEASE | BRISTOL MYERS SQUIBB CO (US) | 2002-06-26 | — | — | EP | disclosed |
| EP-0951293-A1 | METHOD FOR TREATING ALZHEIMER'S DISEASE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-10-27 | — | — | EP | disclosed |
| WO-1998019690-A1 | METHOD FOR TREATING ALZHEIMER'S DISEASE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-05-14 | — | — | WO | disclosed |